CSBR:NASDAQ
Champions Oncology Inc
US$4,70
arrow_upward
+1,18%(+0,055) 1D
13 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4,57
High
US$4,70
Low
US$4,52
Mkt. cap
65,49 ລ້ານ
Avg. vol.
8,16 ພັນ
Volume
3,02 ພັນ
52-wk high
US$8,31
52-wk low
US$4,52
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
Open
US$4,57
High
US$4,70
Low
US$4,52
Mkt. cap
65,49 ລ້ານ
Avg. vol.
8,16 ພັນ
Volume
3,02 ພັນ
52-wk high
US$8,31
52-wk low
US$4,52
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
News stories
From web sources and news partners
Reuters
·
18 ຊົ່ວໂມງກ່ອນ
S&P 500, Nasdaq end lower as Nvidia uncertainty weighs on tech shares
marketscreener.com
·
7 ຊົ່ວໂມງກ່ອນ
S&P 500 Posts Weekly Gain as Energy Sector Leads Broad Climb
Investing.com
·
7 ຊົ່ວໂມງກ່ອນ
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.10%
Traders Union
·
8 ຊົ່ວໂມງກ່ອນ
S&P 500 gains $1.2 trillion in a week, Peter Tuchman notes
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ນິວເຈີຊີ, ສະຫະລັດ
SectorHealth Care
Industry-
Websitechampionsoncology.com